1. St. Jude Medical CEO: second quarter was “absolutely awesome”

    St. Jude Medical CEO: second quarter was “absolutely awesome”
    Normally, you wouldn’t expect the CEO of a major medical device company to employ the phrase “absolutely awesome” during a conference call with Wall Street analysts. But then again, you really can’t blame St. Jude Medical Inc. (NYSE: STJ) CEO Dan Starks for showing a little enthusiasm. Starks was specifically referring to the initial sales of the company’s newest initial cardioverter defibrillators (ICDs) but he might as well been describing STJ’s second quarter performance. In short, STJ kicked major butt, especially in its core ICD and pacemaker business. The company said second quarter profits soared nearly ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

    1. I don't think we have had such a rich technology era as we have now...It’s about the value of our technology advantage. Anytime there is a crisis, there will be winners and losers. But we have done a good job in being proactive enough to position us to be a winner in this current economic environment. We’ve offered some good evidence St. Jude has been an absolute winner.
  3. Topics Mentioned